Figure 1.

Dose-effect of glucagon-like peptide 1. Plasma glucose, pancreatic polypeptide(HPP), and incremental glucagon responses to breakfast with subcutaneous injection of varying doses of GLP-1 with usual insulin in volunteers with type 1 diabetes.

Behme et al. BMC Endocrine Disorders 2003 3:3   doi:10.1186/1472-6823-3-3
Download authors' original image